Clinical data on treatment regimen and use of medication among patients with hemophilia B in Korea.

ABSTRACT:

Background

To investigate the clinical treatment status, such as treatment regimen, bleeding events, and drug dose, in patients with hemophilia B in South Korea.

Methods

In this retrospective chart review, data of patients with hemophilia B from eight university hospitals were collected. Demographic and clinical data, treatment data, such as regimen and number of injections, dose of factor IX concentrate, and bleeding data were reviewed. Descriptive analyses were performed with annual data for 2019, 2020, and 2021, as well as the three years consecutively.

Results

The medical records of 150 patients with hemophilia B between January 1, 2019, and December 31, 2021, were collected. Among these, 72 (48.0%) were severe, 47 (31.3%) were moderate, and 28 (18.7%) were mild.

SUBMITTER: Park YS 

PROVIDER: S-EPMC11310372 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature